FeesSafety
Pluang+

Japan's BOJ rate hikes could disrupt US tech stocks and global liquidity via shrinking yield spreads.

Market News
14 Sep 2026
Seeking Alpha
View Source
Neutral
Japan's BOJ rate hikes could disrupt US tech stocks and global liquidity via shrinking yield spreads.

Japan's Bank of Japan (BOJ) is expected to raise interest rates toward 2%, ending its negative real rate policy and significantly narrowing the yield spread between Japan and the US. This shift threatens the profitability of the Yen-carry trade, which could lead to a global liquidity drain. The rate hikes may notably impact US equities, especially tech-heavy indexes like the S&P 500 and NASDAQ 100. Investors are advised to consider Japanese financial, insurance, and trading stocks, which could outperform if Japan continues to raise rates.

The S&P 500 catalysts including Japan's Bank of Japan rate changes provide context for market activity. For readers following US Financials, here is Pluang's market snapshot as of Sep 14, 2026 22:25 WIB: breadth of 74 priced Financials-sector US stocks shows 23 rose and 50 fell today. Notable movers include BBVA at USD 28.92 (-2.13%), SAN at USD 14.65 (-2.07%), and AON at USD 308.58 (+1.95%).

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
46 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App